Jukka Schildt

1.1k total citations
21 papers, 545 citations indexed

About

Jukka Schildt is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Jukka Schildt has authored 21 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Physiology. Recurrent topics in Jukka Schildt's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Jukka Schildt is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Neuroendocrine Tumor Research Advances (4 papers) and Sarcoidosis and Beryllium Toxicity Research (4 papers). Jukka Schildt collaborates with scholars based in Finland and United States. Jukka Schildt's co-authors include Markku Kupari, Jukka Lehtonen, Riina Kandolin, Kaisa Salmenkivi, Marit Granér, Sari Kivistö, Marko Seppänen, Camilla Schalin‐Jäntti, Irina Lisinen and Ilkka Heiskanen and has published in prestigious journals such as The American Journal of Cardiology, Annals of the Rheumatic Diseases and Journal of Internal Medicine.

In The Last Decade

Jukka Schildt

21 papers receiving 538 citations

Peers

Countries citing papers authored by Jukka Schildt

Since Specialization

Citations

This map shows the geographic impact of Jukka Schildt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jukka Schildt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jukka Schildt more than expected).

Fields of papers citing papers by Jukka Schildt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jukka Schildt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jukka Schildt. The network helps show where Jukka Schildt may publish in the future.

Co-authorship network of co-authors of Jukka Schildt

This figure shows the co-authorship network connecting the top 25 collaborators of Jukka Schildt. A scholar is included among the top collaborators of Jukka Schildt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jukka Schildt. Jukka Schildt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Circulating Tumor DNA in Head and Neck Squamous Cell Carcinoma: Association with Metabolic Tumor Burden Determined with FDG-PET/CT 2023 ·Cancers ·(unknown), Jukka Laine, Katri Aro, (unknown), Leif Bäck, Jukka Schildt, Jussi Hirvonen, Jaana Hagström, Heikki Irjala, Leena‐Maija Aaltonen, Marko Seppänen, Heikki Minn	15
2	PET-CT detection of local residual laryngeal carcinoma after definitive (chemo)radiotherapy 2023 ·BMC Cancer ·(unknown), Taru Ilmarinen, Timo Atula, Katri Aro, Jukka Schildt, Antti Markkola	2
3	Pancreatic imaging in MEN1—comparison of conventional and somatostatin receptor positron emission tomography/computed tomography imaging in real-life setting 2023 ·European Journal of Endocrinology ·(unknown), (unknown), Jukka Schildt, Helka Parviainen, Saila Kauhanen, Hanna Seppänen, Päivi J. Miettinen, Niina Matikainen, Eeva Ryhänen, Camilla Schalin‐Jäntti	4
4	Incidence and Predictors of Atrial Fibrillation in Cardiac Sarcoidosis 2022 ·JACC. Cardiovascular imaging ·(unknown), Valtteri Uusitalo, Pauli Pöyhönen, Jukka Schildt, Jukka Lehtonen, Markku Kupari	20
5	Prospective comparison of 18F-PSMA-1007 PET/CT, whole-body MRI and CT in primary nodal staging of unfavourable intermediate- and high-risk prostate cancer 2021 ·European Journal of Nuclear Medicine and Molecular Imaging ·Simona Malaspina, (unknown), Pekka Taimen, Ivan Jambor, (unknown), Irina Rinta‐Kiikka, Sami Kajander, Jukka Schildt, Ekaterina Saukko, Tommi Noponen, Jani Saunavaara, Peter B. Dean, Roberto Blanco Sequeiros, Hannu J. Aronen, Jukka Kemppainen, Marko Seppänen, Peter J. Boström, Otto Ettala	32
6	Adalimumab and sulfasalazine in alleviating sacroiliac and aortic inflammation detected in PET/CT in patients with axial spondyloarthritis: PETSPA 2021 ·Immunity Inflammation and Disease ·(unknown), Anne M Kerola, Riitta Tuompo, Heikki Relas, Antti Loimaala, (unknown), Jukka Schildt, Tuomas Kerola, Kari K. Eklund, Markku Kauppi, Tuomo Nieminen	3
7	Correlation of Somatostatin Receptor 1–5 Expression, [68Ga]Ga-DOTANOC, [18F]F-FDG PET/CT and Clinical Outcome in a Prospective Cohort of Pancreatic Neuroendocrine Neoplasms 2021 ·Cancers ·(unknown), Tiina Vesterinen, Hanna Seppänen, Harri Mustonen, Jari Sundström, Camilla Schalin‐Jäntti, Risto Gullichsen, Jukka Schildt, Jukka Kemppainen, Johanna Arola, Saila Kauhanen	9
8	Prediction of the aggressiveness of non-functional pancreatic neuroendocrine tumors based on the dual-tracer PET/CT 2019 ·EJNMMI Research ·(unknown), Hanna Seppänen, Jukka Kemppainen, (unknown), Camilla Schalin‐Jäntti, Risto Gullichsen, Jukka Schildt, Harri Mustonen, Tiina Vesterinen, Johanna Arola, Saila Kauhanen	21
9	AB0838 The efficacy of adalimumab and sulfasalazine in alleviating axial and aortic inflammation detected in pet/ct in patients with axial spondyloarthritis 2018 ·Annals of the Rheumatic Diseases ·(unknown), Anne M Kerola, Riitta Tuompo, Markku Kauppi, Heikki Relas, Antti Loimaala, (unknown), Jukka Schildt, Tuomas Kerola, Kari K. Eklund, Tuomo Nieminen	2
10	Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of 231 patients 2017 ·European Heart Journal - Cardiovascular Imaging ·Jukka Schildt, Antti Loimaala, Eero Hippeläinen, Aapo Ahonen	16
11	F-18-Fluorodeoxyglucose Positron Emission Tomography-Guided Sampling of Mediastinal Lymph Nodes in the Diagnosis of Cardiac Sarcoidosis 2015 ·The American Journal of Cardiology ·Piia Simonen, Jukka Lehtonen, Riina Kandolin, Jukka Schildt, (unknown), Heikki Miettinen, Juhani Airaksinen, Tapani Vihinen, Suvi Tuohinen, Petri Haataja, Markku Kupari	37
12	Combining FDG-PET and 99mTc-SPECT to predict functional outcome after coronary artery bypass surgery 2015 ·European Heart Journal - Cardiovascular Imaging ·(unknown), Jukka Schildt, Aapo Ahonen, Päivi Nikkinen, Kirsi Lauerma, Juha Sinisalo, Esko Kankuri, Antti Vento, Tommi Pätilä, Ari Harjula, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	7
13	Seasonal Temperature Changes Do Not Affect Cardiac Glucose Metabolism 2015 ·PubMed ·Jukka Schildt, Antti Loimaala, Eero Hippeläinen, Päivi Nikkinen, Aapo Ahonen	1
14	^99mTechnetium Sestamibi-¹²³Iodine Scintigraphy Is More Accurate Than ^99mTechnetium Sestamibi Alone before Surgery for Primary Hyperparathyroidism 2015 ·PubMed ·Eeva Ryhänen, Jukka Schildt, Ilkka Heiskanen, (unknown), Aapo Ahonen, Eliisa Löyttyniemi, Camilla Schalin‐Jäntti, Matti Välimäki	4
15	Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: A prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass 2014 ·The Journal of Heart and Lung Transplantation ·Tommi Pätilä, (unknown), Antti Vento, Jukka Schildt, Juha Sinisalo, Mika Laine, Pekka Hämmäinen, Anne Nihtinen, Riitta Alitalo, Päivi Nikkinen, Aapo Ahonen, Miia Holmström, Kirsi Lauerma, Reino Pöyhiä, Markku Kupari, Esko Kankuri, Ari Harjula	56
16	FDG-PET/CT in the Assessment of Treatment Response after Oncologic Treatment of Head and Neck Squamous Cell Carcinoma 2014 ·PubMed ·Harri Keski–Säntti, (unknown), Jukka Schildt, Kauko Saarilahti, Antti Mäkitie	10
17	Planar Scintigraphy with ¹²³I/^99mTc-Sestamibi, ^99mTc-Sestamibi SPECT/CT, ¹¹C-Methionine PET/CT, or Selective Venous Sampling Before Reoperation of Primary Hyperparathyroidism? 2013 ·Journal of Nuclear Medicine ·Camilla Schalin‐Jäntti, Eeva Ryhänen, Ilkka Heiskanen, Marko Seppänen, Johanna Arola, Jukka Schildt, (unknown), Lassi Nelimarkka, Irina Lisinen, Ville Aalto, Pirjo Nuutila, Matti Välimäki	43
18	Comparison of Five Parathyroid Scintigraphic Protocols 2013 ·PubMed ·(unknown), (unknown), Jukka Schildt, Aapo Ahonen, Tomi Kauppinen, Irina Lisinen, Anu Holm, Hannu Eskola, Marko Seppänen	28
19	Diagnosing isolated cardiac sarcoidosis 2011 ·Journal of Internal Medicine ·Riina Kandolin, Jukka Lehtonen, Marit Granér, Jukka Schildt, Kaisa Salmenkivi, Sari Kivistö, Markku Kupari	165
20	Complementary Roles of ¹⁸F-DOPA PET/CT and ¹⁸F-FDG PET/CT in Medullary Thyroid Cancer 2011 ·Journal of Nuclear Medicine ·Saila Kauhanen, Camilla Schalin‐Jäntti, Marko Seppänen, Sami Kajander, Sami Virtanen, Jukka Schildt, Irina Lisinen, Aapo Ahonen, Ilkka Heiskanen, (unknown), Johanna Arola, Pirkko Korsoff, Tapani Ebeling, Timo Sane, Heikki Minn, Matti Välimäki, Pirjo Nuutila	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact